👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Mark Henry Tuthill
Oncology
English
French
2,922+
Patients seen
5
Years in practice
8
Publications
2
Languages spoken
About
Special clinical interest in breast, prostate, kidney and bladder cancer
Dr Mark Tuthill is a Consultant Medical Oncologist who specialises in the treatment of early and recurrent cancers of the breast, prostate, kidney and bladder. In 2015, he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, where, in addition, he acts as Chief and Principal investigator on a number of clinical trials.
Dr Tuthill focuses on providing a patient-centred approach to treatment ensuring clear communication, evidence-based therapies and molecularly targeted therapies to enable personalised medicine. Treatments can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors and experimental treatments given as part of clinical trials.
Dr Tuthill originally qualified from University College London and trained in Medical Oncology in London. He holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. Dr Tuthill is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer and is a member of The Association of Cancer Physicians.
Dr Tuthill's research interests include cancer vaccines, tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a Chief, principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types.
NHS Hospital
• The Churchill Hospital
• Oxford University Hospitals NHS Foundation Trust
Dr Mark Tuthill is a Consultant Medical Oncologist who specialises in the treatment of early and recurrent cancers of the breast, prostate, kidney and bladder. In 2015, he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, where, in addition, he acts as Chief and Principal investigator on a number of clinical trials.
Dr Tuthill focuses on providing a patient-centred approach to treatment ensuring clear communication, evidence-based therapies and molecularly targeted therapies to enable personalised medicine. Treatments can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors and experimental treatments given as part of clinical trials.
Dr Tuthill originally qualified from University College London and trained in Medical Oncology in London. He holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. Dr Tuthill is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer and is a member of The Association of Cancer Physicians.
Dr Tuthill's research interests include cancer vaccines, tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a Chief, principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types.
NHS Hospital
• The Churchill Hospital
• Oxford University Hospitals NHS Foundation Trust
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mark Henry Tuthill
Education & training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncology
-
2021–2022 Fellowship · Subspecialty training
Career & appointments
-
2021-09–2022-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 420 |
| Annual physical exam | 99395 | 138 |
| Vaccination administration | 90471 | 2,130 |
| Minor procedure (skin) | 17110 | 2,733 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 9
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3729/euroclin.2025.0 · PMID: 36092234 · cited by 36
-
European registry analysis of Oncology outcomes
DOI: 10.3156/euroclin.2024.1 · PMID: 34233119 · cited by 38
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2022
- national college of family doctors — Member · since 2022
- European Union of Medical Specialists (UEMS) — Member · since 2022
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.mark.tuthill.1@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
